Medicine and Dentistry
Budesonide/Formoterol
77%
Chronic Obstructive Pulmonary Disease
100%
Clinical Trial
22%
Corticosteroid
11%
Disease Severity
55%
Drug Therapy
11%
Forced Expiratory Volume
11%
Lung
22%
Patient
88%
Peak Expiratory Flow
11%
Post-Hoc Analysis
11%
Symptom
33%
Therapeutic Procedure
66%
Tiotropium Bromide
11%
Nursing and Health Professions
Budesonide/Formoterol
77%
Clinical Outcome
11%
Corticosteroid
11%
Disease Severity
55%
Forced Expiratory Volume
11%
Inpatient
66%
Obstructive Lung Disease
100%
Peak Expiratory Flow
11%
Placebo
55%
Post Hoc Analysis
11%
Procedures
11%
Randomization
11%
Symptom
33%
Tiotropium Bromide
11%
Pharmacology, Toxicology and Pharmaceutical Science
Agonist
22%
Budesonide Plus Formoterol
77%
Chronic Obstructive Lung Disease
100%
Corticosteroid
11%
Disease Severity
55%
Symptom
33%